The reliability, validity, and preliminary responsiveness of the Eye Allergy Patient Impact Questionnaire (EAPIQ)

Health and Quality of Life Outcomes

Volumn 3, Issue , 2005, Pages

  Alexander, Michael ^a   Berger, William ^b   Buchholz, Patricia ^c   Walt, John ^d   Burk, Caroline ^e   Lee, Jeff ^d   Arbuckle, Rob ^f   Abetz, Linda ^f  

^a Niagara Clinical Research   (Canada)

^b Souhtern California Research   (United States)

^c IDS SCHEER AG   (Germany)

^d ALLERGAN INC   (United States)

^e CT Burk Inc   (United States)

^f MAPI VALUES   (United States)

Author keywords

EAPIQ; Ocular allergy; Patient functioning; Patient reported outcomes; Psychometric validation

Indexed keywords

ALLERGY; ARTICLE; AUTUMN; CONTROLLED STUDY; CORRELATION ANALYSIS; DAILY LIFE ACTIVITY; DATA ANALYSIS; DISEASE SEVERITY; EMOTIONALITY; EVIDENCE BASED MEDICINE; EYE DISEASE; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PATIENT SATISFACTION; PRODUCTIVITY; PSYCHOMETRY; QUESTIONNAIRE; RATING SCALE; RELIABILITY; RHINOCONJUNCTIVITIS; SEASONAL ALLERGIC CONJUNCTIVITIS; SEASONAL VARIATION; SELF CONCEPT; SOCIAL PSYCHOLOGY; SYMPTOMATOLOGY; VALIDATION PROCESS; WINTER; ADULT; AGED; ALLERGIC CONJUNCTIVITIS; CANADA; INSTRUMENTATION; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; SICKNESS IMPACT PROFILE; TREATMENT OUTCOME; UNITED STATES; VALIDATION STUDY;

ADULT; AGED; CANADA; CONJUNCTIVITIS, ALLERGIC; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; SICKNESS IMPACT PROFILE; TREATMENT OUTCOME; UNITED STATES;

EID: 27744515493     PISSN: 14777525     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-3-67     Document Type: Article

References (16)

1. Bhargava A, Jackson WB, El-Defrawy SR: Ocular allergy disease. Drugs Today 1998; 34: 957-971.
2. Wood B: New treatments to relieve ocular allergies. Rev Optom 1999; 136:124-135.
3. Knight A: The role of levocabastine in the treatment of allergic rhinoconjunctivitis. Br J Clin Pract 1994; 48:139-143.
4. Walt J, Wojcik A, Buchholz P: Initial Development and Validation of the Eye Allergy Patient Impact Questionnaire (EAPIQ). Poster presented at the Annual Meeting of the International Society for Quality of Life Research (ISOQOL) October 30 - November 2, 2002, Orlando Florida, USA.
5. Buchholz P., Walt J., Lorenz D.G., Burk C., Lee J. Patient Impact of Allergic Conjunctivitis as measured by the Eye Allergy Patient Impact Questionnaire (EAPIQ). Poster presented at the Annual Meeting of the Association for Research in Vision and Opthalmology, (ARVO); May 4-9, 2003; Ft. Lauderdale, FL.
6. Juniper EF, Thompson AK, Ferrie PJ, Roberts JN: Development and validation of the mini Rhinoconjunctivitis Quality of Life Questionnaire. Clin Exp Allergy 2000; 30: 132-140.
7. Feeny DH, Torrance GW, Furlong WJ: Health Utilities Index. In Quality of Life and Pharmacoeconomics in Clinical Trials. Second edition. Edited by: Spilker B. Philadelphia: Lippincott-Raven Press; 1996:239-252.
8. Ware JEJ, Snow KK, Kosinski M, Gandek B: SF-36 Health Survey Manual and Interpretation Guide. Boston; USA: New England Medical Center, 1993.
9. Hays RD, Hayashi T: Beyond internal consistency reliability: Rationale and user's guide for Multitait Analysis Program on the microcomputer. Behav Res Methods 1990; 22:167-175.
10. Campbell DT, Fiske JL: Convergent and discriminant validation by the Multitrait multimethod matrix. Psychol Bull 1959; 56:81-105.
11. Cronbach LJ: Coefficient alpha and the internal structure of tests. Psychometrika 1951; 16:297-334.
12. Nunnaly JC, Bernstein IR: Psychometric Theory 3rd edition. New York: McGraw-Hill. Chapter 7 The Assessment of Reliability 1994, p248-292.
13. Chassany O, Sagnier P, Marquis P, Fulleton S, Aaronson N: Patient-Reported outcomes: the example of health related quality of life - a European guidance document for the improved integration of health related quality of life assessment in the drug regulatory process. Drug Inf J 2002; 36:209-238.
14. Hays R, Anderson R, Reviki DA: Assessing reliability and validity of measurement in clinical trials. In: Staquet MJ, Hays RD, Fayers PM Eds. Quality of Life Assessment in Clinical Trials. New York: Oxford University Press, 1998.
15. Kazis LE, Anderson JJ, Meenan RF: Effect sizes for interpreting changes in health status. Med Care 1989; 27:S178-S189.
16. Ware JE, Hams WJ, Gandek B, Rogers B, Reese PR: MAP-R for Windows: multitrait/multi-item analysis porgram-revised. Users guide. Boston: health Assessment Lab; 1997.